Most CEOs believe they make decisions through logic — that strategy, data, and experience lead the process. But every decision begins in a body and brain already biased by what came before. The confidence you feel in a boardroom, the urgency that drives a new initiative, or the fatigue that blunts your focus at the end of a quarter — none of these start at zero. Each moment carries the residue of chemistry: the reward of what went right, the relief of what avoided pain, and the tension of what remains unresolved.
This repeating pattern — the one that makes conviction feel certain and hesitation feel wrong — is what we call the Neurochemical Decision Cycle. It unfolds in three stages: Decision-Making, Daily Execution, and Recovery & Rest.
These stages are not isolated moments. Each one shapes the next. The dopamine that rewards progress in one phase becomes overconfidence in the next. The cortisol that keeps you alert under pressure becomes over-vigilance when pressure ends. And by the time you reach a new decision, you’re already carrying the chemical momentum of the last one.
This is not a theory built on hypotheticals. In our study of 100 CEOs and senior executives in the UK technology sector — leaders running businesses with turnover between £2 million and £40 million — the same patterns appeared with remarkable consistency across all three stages. The findings from that study run throughout this article.
The Architecture of the Cycle
Imagine every major choice — a strategy pivot, a new hire, a market entry — as part of a living system that constantly loops between action and recovery. In one phase, you decide. In the next step, you execute. In the final phase, you recover — or fail to. When this system runs unconsciously, chemistry decides before logic speaks. When you learn to regulate it, clarity compounds rather than distorts. The key is recognising the forces that drive it.
Stage 1 — Decision-Making
Where conviction feels rational long before it is.
Long before a strategy feels “right,” the brain has already rewarded it with dopamine for fitting a familiar pattern. The surge of relief, confidence, or alignment feels like logic — but it’s chemistry. That’s Dopamine-Driven Momentum, the Dopamine Feedback Loop. When an idea aligns with what you hope is true, the mind releases dopamine, and conviction forms faster than validation. You start building around the sense of correctness rather than around the evidence itself.
At the same time, another loop operates quietly in the background: Cortisol-Driven Discomfort, the Cortisol Feedback Loop. When contradiction appears — a red flag in the data, a concern from a board member — it produces a flicker of tension. The brain interprets that discomfort as a problem to remove. So it rationalises, reframes, or moves on. The relief that follows feels like clarity, and the loop repeats. Over time, momentum and avoidance reinforce each other: dopamine accelerates conviction, while cortisol creates the discomfort that pushes you to move past friction, and the decision feels balanced even when it isn’t.
This is why smart leaders sometimes remain committed to flawed directions long after logic should have intervened. The conviction is real, but it can be chemically driven.
And it is far more common than most leaders assume. In our study, 81% of CEOs fell into the High range of dopamine-driven momentum in decision-making, and 80% into the High range of cortisol-driven discomfort. In most cases, conviction had formed before scrutiny was complete — and in the moment, it felt exactly like experience, clarity, and good judgment.
Stage 2 — Daily Execution
Where focus, consistency, and resistance collide.
Once a decision is made, chemistry changes shape. In execution, dopamine drives energy toward what feels rewarding, while cortisol pulls attention away from what feels heavy. The result can be a day full of motion — but not always of progress.
Dopamine-Driven Activity, the Dopamine Feedback Loop, shows up as a strong pull toward what feels rewarding. A new idea, positive feedback, or a quick win releases dopamine and re-orders your priorities on the spot. You feel a rush of progress and dive in. Work that lacks stimulation — strategy, follow-through, difficult conversations — quietly slides down the list. You tell yourself you’re being responsive, but in reality, your attention is being steered by chemistry, not by importance.
Meanwhile, cortisol is shaping a parallel story. It shows up as Cortisol-Driven Resistance, the Cortisol Feedback Loop, inside your day-to-day work. You know the moment: you open something important, and suddenly it feels heavy. You’re not sure where to start. So you switch to something easier — a quick email, a small task. The moment you switch, you feel better. That relief reinforces the pattern. Over time, avoidance starts to feel like prioritisation. You stay busy, the day feels full, but the work that actually matters only moves when pressure forces it.
The cost of these two patterns is measurable. Across our study, they accounted for an average of 51 days of lost progress per team of ten, every month — 23 days from attention shifting toward what feels rewarding, and 28 days from resistance delaying the work that matters most. None of it registered as distraction. The days felt full, and the activities that filled them were often genuinely valuable. The sequence driving them was not.
Awareness of these loops means noticing when your sense of progress is being chemically engineered. When you can tell the difference between real advancement and the feeling of advancement, execution stops drifting and starts compounding.
Stage 3 — Recovery & Rest
Where the next decision quietly begins.
For many executives, this is the invisible stage — the one that determines whether tomorrow starts from clarity or from what your nervous system is still carrying from today. After the intensity of decision and execution, the body is meant to reset. Yet dopamine and cortisol often keep the nervous system running long after the workday ends.
The Dopamine-Driven Continuation, the Dopamine Feedback Loop, keeps your mind running on everything from the day. You step away from work, but your mind keeps going — decisions, conversations, ideas, loose ends. You replay, refine, and think ahead. The same drive that helped you stay engaged now prevents you from switching off. The chemistry doesn’t stop just because the day ends.
At the same time, Cortisol-Driven Alertness and the Cortisol Feedback Loop remain active. The working day is finished, but the body remains slightly tense, and the mind keeps scanning for problems or risks. The nervous system is still releasing cortisol, so alertness continues in the background. You wake up at night thinking about conversations, decisions, or what could go wrong. The mind just keeps going because your nervous system is still carrying the day’s stress.
Here too, the pattern is near-universal. In our study, 72% of CEOs fell into the High range for dopamine-driven continuation, and 85% into the High range for cortisol-driven alertness during recovery and rest. For most, the working day did not end. It was carried.
This incomplete reset is why performance sometimes drops or becomes inconsistent, even in high-functioning leaders. It’s not a failure of discipline; it’s biology. The next morning begins from a biased baseline — momentum and vigilance inherited rather than chosen. True recovery is the deliberate act of returning the nervous system to neutral so that the next cycle starts clean.
How the Cycle Becomes Culture
These patterns do not stay at the individual level — and this is one of the most significant findings in our research.
CEOs naturally build executive teams of people who think in similar ways: those who align quickly, see the same opportunities, and reach conclusions quickly and with confidence. From the outside, this looks like strong leadership alignment. In practice, it often means that the same neurochemical patterns that shape the CEO’s decisions are replicated and validated at the most senior level of the business.
From there, the pattern spreads further. Teams learn — without being told — what gets reinforced, what gets moved past, and how fast direction is set. They adapt to it. Over time, it stops being one leader’s pattern and becomes the organisation’s default way of thinking, deciding, and executing.
What began as an internal chemical response in one person becomes the culture of an entire business.
Regulating the Cycle
The Neurochemical Decision Cycle is the operating system that enables both conviction and resilience. The problem arises when it runs on autopilot. When you regulate it consciously, dopamine becomes a source of drive rather than a source of distortion, and cortisol becomes a signal to focus rather than a cue to avoid. Each stage then performs its true function: decisions grounded in clarity, execution aligned with strategy, recovery that actually restores.
You don’t need to dismantle instinct or emotion. You just need to know when chemistry is steering logic instead of supporting it. The goal is the ability to decide, act, and recover from a balanced baseline rather than from inherited bias.
Here is how one CEO described what that shift looked like in practice:
“Working with Tomasz Drybala on his neuro-based leadership programme has had a powerful impact on both me personally and my leadership and sales teams. His ability to translate neuroscience, and in particular dopamine and cortisol loops, into practical leadership behaviours has positively changed how we operate. We now better understand what truly drives motivation, performance, and decision-making under pressure. As a result, our leadership is more intentional, our sales execution is sharper, and our organisation is operating with greater focus and resilience.”
— Ross Teague, Chief Executive Officer, Nebula Global Services
See Your Own Cycle
Every leader’s chemistry has a pattern. Once it’s mapped, it becomes visible in every decision, project, and recovery habit you have. The Neurochemically Optimised Executive Assessment reveals this map — showing how dopamine and cortisol shape your logic across Decision-Making, Daily Execution, and Recovery & Rest.
It isn’t a personality test. It measures the intensity of the internal signals — reward, avoidance, alertness — that shape your decisions before logic engages. It takes five minutes, it’s free, and it gives you the same baseline measurement used with the 100 CEOs in our study.
To explore the full findings behind this article, visit the Study of 100 CEOs.
About the author
Tomasz Drybala is the founder of the Neuro-Based Leadership Centre and the architect of a neuroscience-based regulatory framework designed for CEOs, founders, and senior executives. His work focuses on measuring and regulating the neurochemical feedback loops that shape executive decision-making, daily execution, and recovery cycles — operating at the level where perception is formed, before logic engages. Alongside building his executive framework, he pursued targeted programs through institutions including Harvard, Cambridge, Oxford, and the University of California, Berkeley, and leads an applied research body that examines how feedback loops involving dopamine, cortisol, oxytocin, serotonin, and testosterone influence judgment, timing, and execution in real organisational environments.